Evidence map›Paper›PMID 26871371›Full record

ArticlePharmacogenomics2016

Perceptions of pharmacogenetic research to guide tobacco cessation by patients, providers and leaders in a tribal healthcare setting.

Jaedon P Avey, Vanessa Y Hiratsuka, Julie A Beans, Susan Brown Trinidad, Rachel F Tyndale, Renee F Robinson

Abstract read
In one paragraph

Article in Pharmacogenomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Identification of Sociodemographic, Clinical, and Genetic Factors to Aid Alaska Native and American Indian People to Successfully Quit Smoking.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Observational
  9. The ELSI Virtual Forum, 30 Years of the Genome: Integrating and Applying ELSI Research.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jaedon P AveyResearch Department, Southcentral Foundation, 4105 Tudor Centre Drive, Anchorage, AK 99508, USA.
Vanessa Y HiratsukaResearch Department, Southcentral Foundation, 4105 Tudor Centre Drive, Anchorage, AK 99508, USA.
Julie A BeansResearch Department, Southcentral Foundation, 4105 Tudor Centre Drive, Anchorage, AK 99508, USA.
Susan Brown TrinidadDepartment of Bioethics & Humanities, University of Washington, Box 357120, Seattle, WA 98195-7120, USA.
Rachel F TyndaleCampbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Departments of Psychiatry, and Pharmacology & Toxicology, University of Toronto, Medical Science Building Room 4326, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada.
Renee F RobinsonResearch Department, Southcentral Foundation, 4105 Tudor Centre Drive, Anchorage, AK 99508, USA.

Funding

HEALTH SERVICES RESEARCH FELLOWSHIPT32HS000079 · AHRQ · DUKE UNIVERSITY · PI EDELMAN, DAVID · 1998 to 2013
$1.9M
METHODS TO DIAGNOSE AND PREVENT THE SPREAD OF TBF32HS000079 · AHRQ · MASSACHUSETTS GENERAL HOSPITAL · PI BREWER, TIMOTHY F. · 1993 to 1995
–
AHRQ HHS F32 HS000079AHRQ HHS T32 HS000079PHS HHS U261IHS0079
6 · The paper itself

Abstract

aimDescribe patients,' providers' and healthcare system leaders' perceptions of pharmacogenetic research to guide tobacco cessation treatment in an American Indian/Alaska Native primary care setting. MATERIALS &

methodsThis qualitative study used semistructured interviews with 20 American Indian/Alaska Native current or former tobacco users, 12 healthcare providers and nine healthcare system leaders.

resultsParticipants supported pharmacogenetic research to guide tobacco cessation treatment provided that a community-based participatory research approach be employed, research closely coordinate with existing tobacco cessation services and access to pharmacogenetic test results be restricted to providers involved in tobacco cessation.

conclusionDespite a history of mistrust toward genetic research in tribal communities, participants expressed willingness to support pharmacogenetic research to guide tobacco cessation treatment.

Indexed as

Health Knowledge, Attitudes, PracticeIndians, North AmericanPharmacogeneticsAlaskaCommunity-Based Participatory ResearchCommunity-Institutional RelationsHumansPrimary Health CareQualitative ResearchTobacco Use Cessationacademic–community partnershipAmerican Indian/Alaska Nativecommunity-based participatory researchgenetic researchpharmacogeneticstobacco cessation

Identifiers

PMID26871371
PMCPMC5558512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.